Bottom line
Is FXH a good fund? The bottom line
FXH is an actively managed health care sector ETF from First Trust.
Annual fees run 0.61% — about $61 a year on every $10,000 invested, cheaper than 76% of health care sector funds we track.
It returned +1.1% over one year, +4.5% a year over five years, +5.7% a year over ten (as of Dec 31, 2024, per its prospectus).
With $1.0 billion in net assets and 75 holdings, its largest position is Regeneron Pharmaceuticals Inc (2.8%) and the top 10 make up 24.6% of the portfolio.
What stands out
- Low cost: cheaper than 76% of health care sector peers
Updated Nov 19, 2026
What FXH invests in
The First Trust Health Care AlphaDEX Fund (the Fund ) seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the StrataQuant Health Care Index (the Index ).
The Fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Index is part of the StrataQuant Series, a family of custom enhanced indices developed, maintained and owned by ICE Data Indices, LLC or its affiliates ( IDI or the Index Provider ). The Index Provider reserves the right to, at any time, change the number of stocks comprising the Index by adding or deleting one or more stocks, or replacing one or more stocks contained in the Index with one or more substitute stocks of its choice, if in the Index Providers discretion, such addition, deletion or substitution is necessary or appropriate to maintain the quality and/or character of the Index. According to the Index Provider…
From the fund's prospectus (filed Nov 28, 2025).
FXH performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| FXH | +1.1% | +4.5% | +5.7% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2024
What FXH costs
On a $10,000 investment, FXH's 0.61% expense ratio costs about $61 a year. The median health care sector fund charges 0.96%.
FXH top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Regeneron Pharmaceuticals Inc REGN | 2.77% |
| 2 | Universal Health Services Inc UHS | 2.57% |
| 3 | Solventum Corp SOLV | 2.51% |
| 4 | Boston Scientific Corp BSX | 2.48% |
| 5 | Zimmer Biomet Holdings Inc ZBH | 2.47% |
| 6 | Guardant Health Inc GH | 2.45% |
| 7 | Davita Inc DVA | 2.44% |
| 8 | Pfizer Inc PFE | 2.35% |
| 9 | Tenet Healthcare Corp THC | 2.30% |
| 10 | Cigna Group (the) CI | 2.29% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 24.6% of the fund. See all top 25 holdings and asset mix →